- Huajian Medical halts its $410 million ETH acquisition due to delayed shareholder authorization.
- Market strategies impacted, leading to a suspension in plans.
- Future purchases will comply with Hong Kong’s listing rules.
Huajian Medical, a Hong Kong-listed company, has temporarily suspended its plan to purchase ETH worth approximately 3 billion yuan due to shareholder authorization delays as announced by the Hong Kong Stock Exchange.
The pause underscores challenges in executing large-scale cryptocurrency acquisitions within regulated markets, potentially impacting Huajian’s strategic asset tokenization and AI platform integration efforts.
Huajian Medical Halts $410 Million Ethereum Acquisition
Huajian Medical, a Hong Kong-listed entity, recently paused its planned acquisition of Ethereum worth 3 billion yuan. The company aimed to finalize shareholder authorization but needed additional time to secure it, leading to a temporary suspension.
The company will adhere to listing rules set by the Hong Kong Stock Exchange, ensuring that any significant purchases are properly disclosed. This reflects their ongoing commitment to regulatory compliance and transparency.
No official comments from major crypto figures or stakeholders have emerged regarding this suspension. According to an official source, “Future ETH purchases will be publicly disclosed per Chapter 14 of the HK listing rules.” Market observers note the impact on Huajian’s stock performance following its announcement of digital asset strategies earlier in the year.
Traditional Corporations Eyeing Ethereum Amid Regulatory Changes
Did you know? Huajian Medical’s move illustrates an increasing trend where traditional companies explore Ethereum amidst evolving digital asset regulations in Hong Kong.
According to CoinMarketCap, Ethereum (ETH) is priced at $3,868.25, with a market cap of $466.89 billion, holding a 12.59% market dominance. Recent trends reveal the crypto’s 24-hour volume fell by 18.71%, with a 5.93% rise over 90 days.
Ethereum(ETH), daily chart, screenshot on CoinMarketCap at 15:33 UTC on November 2, 2025. Source: CoinMarketCapThe Coincu research team notes that Huajian’s suspension may hint at growing caution within the industry to navigate regulatory landscapes. These dynamics underscore the balance companies must maintain between innovation and compliance.
| DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |
Source: https://coincu.com/news/huajian-eth-acquisition-delay/
